
Artificial Intelligence
MxAI: generative AI to accelerate drug commercialization
How we developed a high-performance generative AI solution for MaxAI, enabling the analysis of +1000 medical documents with 95% accuracy. A startup that reduces drug market entry costs by 80%.
